Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.

Name: Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.
License: Public Domain

ANRS, Emerging Infectious Diseases

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 314396
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.